
Study on MDMA's use to treat PTSD could send therapy method to FDA for approval by 2024
Fox News
A study looking into how MDMA can be used to treat post traumatic stress disorder showed symptoms decreased to levels that could no longer be diagnosed as PTSD
"Thanks to the combined efforts of dozens of therapists, hundreds of participants who volunteered in MAPS-sponsored trials, and many thousands of generous donors, MDMA-assisted therapy for PTSD is on track to be considered for approval by the FDA in 2024," MAPS founder and president Rick Doblin said. Greg Wehner is a breaking news reporter for Fox News Digital.
The results for the third phase of the study were published in Nature Medicine on Sept. 13, 2024.
More Related News













